Chengdu Zenitar Biomedical Technology Co., Ltd

This study tests an experimental drug called purinostat mesylate in 50 adults with peripheral or cutaneous T-cell lymphoma that has returned or stopped responding to standard treatments. The main goal is to see if the drug can shrink or eliminate tumors, while also checking its s…

This study tests a new drug called purinostat mesylate in about 74 adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), a type of blood cancer that has come back or not responded to prior treatments. The goal is to find a safe and effective dose and see how w…